LINING UP TO MAKE A CANCER DRUG.

Focuses on the increasing competition to produce bulk paclitaxel, a derived cancer drug in the U.S. Requirement of a rare combination of farming and chemistry skills; Usability of extractive and semisynthetic approaches in making the drug; History of initiation of clinical trials of drug's antitumor activity by the National Cancer Institute.